Rockefeller Capital Management
WST icon

Rockefeller Capital Management’s West Pharmaceutical WST Stock Holding History

Rockefeller Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$589K Buy
2,351
+922
+65% +$229K ﹤0.01% 1877
2025
Q4 		$393K Buy
1,429
+421
+42% +$115K ﹤0.01% 2029
2025
Q3 		$264K Buy
+1,008
New +$245K ﹤0.01% 2080
2023
Q3 		– Sell
-9,106
Closed -$3.48M – 1832
2023
Q2 		$3.48M Buy
9,106
+5,935
+187% +$2.12M 0.01% 683
2023
Q1 		$1.1M Sell
3,171
-255
-7% -$74.5K ﹤0.01% 1032
2022
Q4 		$804K Sell
3,426
-826
-19% -$196K ﹤0.01% 1090
2022
Q3 		$1.04M Sell
4,252
-162
-4% -$49.4K 0.01% 995
2022
Q2 		$1.33M Sell
4,414
-999
-18% -$325K 0.01% 903
2022
Q1 		$2.22M Sell
5,413
-4,003
-43% -$1.57M 0.01% 768
2021
Q4 		$4.42M Sell
9,416
-246
-3% -$106K 0.02% 578
2021
Q3 		$4.1M Buy
9,662
+2,674
+38% +$1.13M 0.02% 534
2021
Q2 		$2.51M Buy
6,988
+3,093
+79% +$1.02M 0.01% 653
2021
Q1 		$1.1M Buy
3,895
+175
+5% +$50.1K 0.01% 753
2020
Q4 		$1.05M Buy
3,720
+2
+0.1% +$561 0.01% 681
2020
Q3 		$1.02M Buy
3,718
+182
+5% +$48.2K 0.01% 592
2020
Q2 		$803K Buy
3,536
+1,889
+115% +$371K 0.01% 588
2020
Q1 		$251K Buy
1,647
+1,599
+3,331% +$246K ﹤0.01% 767
2019
Q4 		$7K Buy
+48
New +$6.99K ﹤0.01% 1719
2019
Q2 		– Sell
-326
Closed -$36K – 2017
2019
Q1 		$36K Buy
+326
New +$33.9K ﹤0.01% 1019

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rockefeller Capital Management's WST Position: Q1 2026 in Review

Rockefeller Capital Management increased its West Pharmaceutical (WST) stake by 65% in Q1 2026, buying an estimated $229K and bringing the position to 2,351 shares worth $589K. The position accounts for ﹤0.01% of the portfolio, ranked #1877.

Rockefeller Capital Management first reported a position in WST in Q1 2019 and has held it in 19 quarters since. The position peaked at $4.42M in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Rockefeller Capital Management held 2,351 shares of West Pharmaceutical worth $589K as of Q1 2026.
  • Rockefeller Capital Management bought 922 West Pharmaceutical shares in Q1 2026, an estimated $229K.
  • West Pharmaceutical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1877 holding.
  • Rockefeller Capital Management first reported a position in West Pharmaceutical in Q1 2019 and has held it in 19 quarters since.
  • Rockefeller Capital Management's West Pharmaceutical position peaked at $4.42M in Q4 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.